|
|
Volumn 41, Issue 3, 2002, Pages 239-248
|
|
Regional immunotherapy for metastatic renal cell carcinoma;Regionale immuntherapie beim metastasierten nierenzellkarzinom
|
|
Author keywords
Immunotherapy; Interferon; Interleukin 2; Renal cell carcinoma
|
|
Indexed keywords
RECOMBINANT INTERLEUKIN 2;
ANTINEOPLASTIC AGENT;
INTERLEUKIN 2;
BREAST CARCINOMA;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CAPILLARY LEAK SYNDROME;
CLINICAL TRIAL;
DRUG EFFICACY;
HUMAN;
KIDNEY CARCINOMA;
LUNG ALVEOLUS CELL CARCINOMA;
LUNG LAVAGE;
LUNG METASTASIS;
MEDIASTINUM METASTASIS;
MELANOMA;
METASTASIS;
OVARY CARCINOMA;
QUALITY OF LIFE;
REVIEW;
ADULT;
AGED;
CANCER STAGING;
FEMALE;
INHALATIONAL DRUG ADMINISTRATION;
KIDNEY TUMOR;
LUNG TUMOR;
MALE;
MIDDLE AGED;
MORTALITY;
PATHOLOGY;
SURVIVAL RATE;
ADMINISTRATION, INHALATION;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
CLINICAL TRIALS;
FEMALE;
HUMANS;
INTERLEUKIN-2;
KIDNEY NEOPLASMS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
SURVIVAL RATE;
|
|
EID: 0038347365
PISSN: 03402592
EISSN: None
Source Type: Journal
DOI: 10.1007/s00120-002-0206-2 Document Type: Review |
|
Times cited : (12)
|
|
References (1)
|
